Skin and soft tissue infections among HIV-infected persons in the late combination antiretroviral therapy era

International Journal of STD and AIDS

Volumn 23, Issue 7, 2012, Pages 507-511

  Crum Cianflone, N F ^a,b   Grandits, G ^c   Weintrob, A ^d   Ganesan, A ^d   Agan, B ^a   Landrum, M ^e  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d WALTER REED ARMY MEDICAL CENTER   (United States)

^e SAN ANTONIO MILITARY MEDICAL CENTER   (United States)

Author keywords

Epidemiology; HIV; MRSA; Risk factors; Skin and soft tissue infection; SSTI

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COMBINATION ANTIRETROVIRAL THERAPY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SKIN AND SOFT TISSUE INFECTION; SKIN INFECTION; SOFT TISSUE INFECTION;

ADULT; ANALYSIS OF VARIANCE; ANTI-RETROVIRAL AGENTS; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MILITARY PERSONNEL; PROSPECTIVE STUDIES; RISK FACTORS; SKIN DISEASES, INFECTIOUS; SOFT TISSUE INFECTIONS; UNITED STATES;

EID: 84864482428     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2011.011360     Document Type: Article

References (20)

1. Popovich KJ, Weinstein RA, Aroutcheva A, Rice T, Hota B. Community-associated methicillin-resistant Staphylococcus aureus and HIV: intersecting epidemics. Clin Infect Dis 2010;50:979-87
2. Crum-Cianflone NF, Burgi AA, Hale BR. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons. Int J STD AIDS 2007;18:521-6
3. Hidron AI, Moanna A, Rimland D. The rise and fall of MRSA infections in HIV patients. AIDS 2011;25:1001-3
4. Kallen AJ, Mu Y, Bulens S, et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010;304:641-8
5. Mathews WC, Caperna JC, Barber RE, et al. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 2005;40:155-60
6. Ramsetty SK, Stuart LL, Blake RT, Parsons CH, Salgado CD. Risk for methicillin-resistant Staphylococcus aureus colonization or infection among patients with HIV infection. HIV Med 2010;11:389-94
7. Szumowski JD, Wener KM, Gold HS, et al. Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men. Clin Infect Dis 2009;49:118-21
8. Lee NE, Taylor MM, Bancroft E, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clin Infect Dis 2005;40:1529-34
9. Diep BA, Chambers HF, Graber CJ, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008;148:249-57
10. Drapeau C, Angeletti C, Festa A, et al. Role of previous hospitalizations in clinically-significant MRSA infection among HIV-infected inpatients: results of a case-control study. BMC Infect Dis 2007;7:36
11. Tumbarello M, de Gaetano Donati K, Tacconelli E, et al. Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J Antimicrob Chemother 2002;50:375-82
12. Burkey MD, Wilson LE, Moore RD, Petrosillo N. The incidence of and risk factors for MRSA bacteremia in an HIV-infected cohort in the HAART era. HIV Med 2008;9:858-62
13. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Washington, DC: Department of Health and Human Services, 2011;1-166. See http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. (last checked 8 July, 2011)
14. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19
15. Graber CJ, Jacobson MA, Perdreau-Remington F, Chambers HF, Diep BA. Recurrence of skin and soft-tissue infection caused by methicillin-resistant Staphylococcus aureus in a HIV primary care clinic. J Acquir Immune Defic Syndr 2008;49:231-3
16. Hersh AL, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008;168:1585-91
17. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-44
18. Talan DA, Krishnadasan A, Gorwitz RJ, et al. for The EMERGEncy ID Net Study Group. Comparison of Staphylococcus aureus from skin and soft tissue infections in US Emergency Department Patients, 2004 and 2008. Clin Infect Dis 2011;53:144-9
19. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783-801
20. Lin L, Ibrahim AS, Xu X, et al. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathogens 2009;5:e1000703